173 related articles for article (PubMed ID: 2450690)
21. Prediction of the therapeutic response to methotrexate at 24 weeks by methotrexate-polyglutamates concentration in erythrocytes at 8 weeks in patients with rheumatoid arthritis.
Murosaki T; Nagatani K; Sato T; Akiyama Y; Ushijima K; Lefor AK; Fujimura A; Minota S
Mod Rheumatol; 2017 May; 27(3):411-416. PubMed ID: 27435295
[TBL] [Abstract][Full Text] [Related]
22. Mercaptopurine metabolite levels are predictors of bone marrow toxicity following high-dose methotrexate therapy of childhood acute lymphoblastic leukaemia.
Vang SI; Schmiegelow K; Frandsen T; Rosthøj S; Nersting J
Cancer Chemother Pharmacol; 2015 May; 75(5):1089-93. PubMed ID: 25788208
[TBL] [Abstract][Full Text] [Related]
23. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
[TBL] [Abstract][Full Text] [Related]
24. Measurement of erythrocyte methotrexate polyglutamate levels: ready for clinical use in rheumatoid arthritis?
Danila MI; Hughes LB; Brown EE; Morgan SL; Baggott JE; Arnett DK; Bridges SL
Curr Rheumatol Rep; 2010 Oct; 12(5):342-7. PubMed ID: 20665136
[TBL] [Abstract][Full Text] [Related]
25. Maintenance chemotherapy for childhood acute lymphoblastic leukemia: relation of bone-marrow and hepatotoxicity to the concentration of methotrexate in erythrocytes.
Schmiegelow K; Schrøder H; Pulczynska MK; Hejl M
Cancer Chemother Pharmacol; 1989; 25(1):65-9. PubMed ID: 2591003
[TBL] [Abstract][Full Text] [Related]
26. Methotrexate in erythrocytes of patients with psoriasis.
Schrøder H; Foged EK
Eur J Clin Pharmacol; 1986; 30(4):453-6. PubMed ID: 3743621
[TBL] [Abstract][Full Text] [Related]
27. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
[TBL] [Abstract][Full Text] [Related]
28. Folic acid supplements in vitamin tablets: a determinant of hematological drug tolerance in maintenance therapy of childhood acute lymphoblastic leukemia.
Schrøder H; Clausen N; Ostergård E; Pressler T
Pediatr Hematol Oncol; 1986; 3(3):241-7. PubMed ID: 3153236
[TBL] [Abstract][Full Text] [Related]
29. Determination of erythrocyte methotrexate polyglutamates by liquid chromatography/tandem mass spectrometry after low-dose methotrexate therapy in Chinese patients with rheumatoid arthritis.
Mo X; Wen Y; Ren B; Chen J; Xu C; Wang X; Huang M; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():41-8. PubMed ID: 22999476
[TBL] [Abstract][Full Text] [Related]
30. Methotrexate pharmacokinetics in age-fractionated erythrocytes.
Schrøder H
Cancer Chemother Pharmacol; 1986; 18(3):203-7. PubMed ID: 3467879
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate in neutrophils in children with acute lymphoblastic leukemia.
Schrøder H
Cancer Chemother Pharmacol; 1987; 19(4):339-42. PubMed ID: 3474084
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate polyglutamate synthesis in lymphoblasts from children with acute lymphoblastic leukemia.
Whitehead VM; Rosenblatt DS; Vuchich MJ; Beaulieu D
Dev Pharmacol Ther; 1987; 10(6):443-8. PubMed ID: 2445535
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of erythrocyte methotrexate after high-dose methotrexate.
Schalhorn A; Sauer H; Wilmanns W; Stupp-Poutot G
Cancer Chemother Pharmacol; 1982; 9(1):65-9. PubMed ID: 7139854
[TBL] [Abstract][Full Text] [Related]
34. Using fluorescence polarization immunoassay for determination of erythrocyte methotrexate polyglutamates, a quick and easy test?
den Boer E; Koch BC; Huisman R; de Jonge R
Ther Drug Monit; 2014 Dec; 36(6):819-23. PubMed ID: 24739667
[TBL] [Abstract][Full Text] [Related]
35. Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia.
Schmiegelow K; Björk O; Glomstein A; Gustafsson G; Keiding N; Kristinsson J; Mäkipernaa A; Rosthøj S; Szumlanski C; Sørensen TM; Weinshilboum R
J Clin Oncol; 2003 Apr; 21(7):1332-9. PubMed ID: 12663723
[TBL] [Abstract][Full Text] [Related]
36. Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates.
Allegra CJ; Chabner BA; Drake JC; Lutz R; Rodbard D; Jolivet J
J Biol Chem; 1985 Aug; 260(17):9720-6. PubMed ID: 2410416
[TBL] [Abstract][Full Text] [Related]
37. Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis.
Angelis-Stoforidis P; Vajda FJ; Christophidis N
Clin Exp Rheumatol; 1999; 17(3):313-20. PubMed ID: 10410264
[TBL] [Abstract][Full Text] [Related]
38. Impairment of methotrexate (MTX)-polyglutamate formation of MTX-resistant K562 cell lines.
Koizumi S
Jpn J Cancer Res; 1988 Nov; 79(11):1230-7. PubMed ID: 2465288
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis.
Dalrymple JM; Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Barclay ML
Arthritis Rheum; 2008 Nov; 58(11):3299-308. PubMed ID: 18975321
[TBL] [Abstract][Full Text] [Related]
40. A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate.
Hobl EL; Jilma B; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Rizovski B; Mader RM
Clin Exp Rheumatol; 2012; 30(2):156-63. PubMed ID: 22152098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
